Skip to content
healthcare.dev

Doxazosin

NDC 59651-895, doxazosin mesylate, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-895
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075509
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE8 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
59651-895-0159651089501100 TABLET in 1 BOTTLE (59651-895-01)
59651-895-99596510895991000 TABLET in 1 BOTTLE (59651-895-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/93f2d724-5a54-4721-b04a-e46bc764607b
  • NADAC price for package 59651089501

    GET /v1/drugs/nadac/59651089501
  • NADAC price for package 59651089599

    GET /v1/drugs/nadac/59651089599

Use it

Look up 59651-895 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.